These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 17301300)

  • 1. Inheritance of a cancer-associated MLH1 germ-line epimutation.
    Hitchins MP; Wong JJ; Suthers G; Suter CM; Martin DI; Hawkins NJ; Ward RL
    N Engl J Med; 2007 Feb; 356(7):697-705. PubMed ID: 17301300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.
    Crépin M; Dieu MC; Lejeune S; Escande F; Boidin D; Porchet N; Morin G; Manouvrier S; Mathieu M; Buisine MP
    Hum Mutat; 2012 Jan; 33(1):180-8. PubMed ID: 21953887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritable germline epimutation is not the same as transgenerational epigenetic inheritance.
    Chong S; Youngson NA; Whitelaw E
    Nat Genet; 2007 May; 39(5):574-5; author reply 575-6. PubMed ID: 17460682
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited epimutation or a haplotypic basis for the propensity to silence?
    Suter CM; Martin DI
    Nat Genet; 2007 May; 39(5):573; author reply 576. PubMed ID: 17460681
    [No Abstract]   [Full Text] [Related]  

  • 5. MLH1 methylation screening is effective in identifying epimutation carriers.
    Pineda M; Mur P; Iniesta MD; Borràs E; Campos O; Vargas G; Iglesias S; Fernández A; Gruber SB; Lázaro C; Brunet J; Navarro M; Blanco I; Capellá G
    Eur J Hum Genet; 2012 Dec; 20(12):1256-64. PubMed ID: 22763379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
    Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
    Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.
    Hitchins M; Williams R; Cheong K; Halani N; Lin VA; Packham D; Ku S; Buckle A; Hawkins N; Burn J; Gallinger S; Goldblatt J; Kirk J; Tomlinson I; Scott R; Spigelman A; Suter C; Martin D; Suthers G; Ward R
    Gastroenterology; 2005 Nov; 129(5):1392-9. PubMed ID: 16285940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline epimutation of MLH1 in individuals with multiple cancers.
    Suter CM; Martin DI; Ward RL
    Nat Genet; 2004 May; 36(5):497-501. PubMed ID: 15064764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline epimutation: A basis for epigenetic disease in humans.
    Martin DI; Ward R; Suter CM
    Ann N Y Acad Sci; 2005; 1054():68-77. PubMed ID: 16339653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility.
    Hitchins MP
    Adv Genet; 2010; 70():201-43. PubMed ID: 20920750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosaic Epigenetic Inheritance as a Cause of Early-Onset Colorectal Cancer.
    Sloane MA; Nunez AC; Packham D; Kwok CT; Suthers G; Hesson LB; Ward RL
    JAMA Oncol; 2015 Oct; 1(7):953-7. PubMed ID: 26181641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.
    Kwok CT; Vogelaar IP; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Rapkins RW; Ward RL; Chun N; Ford JM; Ladabaum U; McKinnon WC; Greenblatt MS; Hitchins MP
    Eur J Hum Genet; 2014 May; 22(5):617-24. PubMed ID: 24084575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline epimutation in humans.
    Cropley JE; Martin DI; Suter CM
    Pharmacogenomics; 2008 Dec; 9(12):1861-8. PubMed ID: 19072644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
    Hitchins MP
    Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer.
    Valle L; Carbonell P; Fernandez V; Dotor AM; Sanz M; Benitez J; Urioste M
    Clin Genet; 2007 Mar; 71(3):232-7. PubMed ID: 17309645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Germ-line epimutations and human cancer].
    Wu PY; Fan YM; Wang YP
    Ai Zheng; 2009 Dec; 28(12):1236-42. PubMed ID: 19958615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.
    Renkonen E; Zhang Y; Lohi H; Salovaara R; Abdel-Rahman WM; Nilbert M; Aittomaki K; Jarvinen HJ; Mecklin JP; Lindblom A; Peltomaki P
    J Clin Oncol; 2003 Oct; 21(19):3629-37. PubMed ID: 14512394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.